関連レポート

パーキンソン病治療薬の世界市場：2031年予測

出版元：Transparency Market Research  出版元について

発行年：2024年4月

定価：Single User License $5795 Multi User License $8795 Corporate User License $11795

ご請求は円換算（お見積り日TTSレート）となります。

ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。

納品形態：PDF by Email

当調査レポートは英文 175ページになります。

商品コード：TMR255

当レポートは発行年月に関わらず、受注の都度、最新情報にアップデートしてお届けいたします。ご希望情報の追加等もご相談可能です。

レポート紹介

アルツハイマー病治療薬の世界市場規模は2023年で40億ドル、2034年に116億ドル、市場の平均年成長率は10.0%増で推移する見通しです。

当レポートでは、アルツハイマー病治療薬の市場予測-2034年、各種セグメント別市場分析(薬物クラス別、販売経路別、国地域別、等)、COVID-19の影響分析、市場シェア分析、主要企業プロフィールなどの情報を盛り込み、概略以下の構成でお届けいたします。

【レポート構成概要】
■アルツハイマー病治療薬の世界市場予測2020-2034年
・市場規模(US$)

■薬物クラス別、市場-2034年
コリン作動性
メマンチン
併用薬
その他
※(市場規模US$)

■販売経路別、市場-2034年
病院薬局
小売薬局
オンライン販売
※(市場規模US$)

■主要国地域別市場-2034年
北米
・米国、カナダ
欧州
・ドイツ、英国、フランス
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・オーストラリア/ニュージーランド
・その他アジア太平洋
中南米
・ブラジル、メキシコ
・中南米
中東アフリカ
・GCC諸国、南アフリカ
・その他中東アフリカ
※地域別に各種セグメント別の細分化データ掲載、詳細は目次参照

■市場分析
市場ダイナミクス（促進要因、障壁、機会）
パイプライン分析
COVID-19の影響分析
競合状況
市場シェア分析

■アルツハイマー病治療薬の主要企業プロフィール動向
Allergan plc
Novartis AG
エーザイ株式会社
Johnson & Johnson
第一三共株式会社
小野薬品工業株式会社
H Lundbeck A/S
Merz Holding GmbH & Co. KG
（全175頁）

Table of Contents (英文詳細目次）

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Alzheimer’s Drugs Market

4. Market Overview
4.1. Introduction
4.1.1. Technology, Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Alzheimer’s Drugs Market Analysis and Forecast, 2020-2034

5. Key Insights
5.1. Pipeline Analysis
5.2. Key Technology, /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry

6. Global Alzheimer’s Drugs Market Analysis and Forecast, by Drug Class
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Drug Class, 2020-2034
6.3.1. Cholinergic
6.3.2. Memantine
6.3.3. Combined Drugs
6.3.4. Others
6.4. Market Attractiveness Analysis, by Drug Class

7. Global Alzheimer’s Drugs Market Analysis and Forecast, by Distribution Channel
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Distribution Channel, 2020-2034
7.3.1. Hospital Pharmacies
7.3.2. Retail Pharmacies
7.3.3. Online Sales
7.4. Market Attractiveness Analysis, by Application

8. Global Alzheimer’s Drugs Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region, 2020-2034
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region

9. North America Alzheimer’s Drugs Market Analysis and Forecast
9.1. Introduction
9.2. Key Findings
9.3. Market Value Forecast, by Drug Class, 2020-2034
9.3.1. Cholinergic
9.3.2. Memantine
9.3.3. Combined Drugs
9.3.4. Others
9.4. Market Value Forecast, by Distribution Channel, 2020-2034
9.4.1. Hospital Pharmacies
9.4.2. Retail Pharmacies
9.4.3. Online Sales
9.5. Market Value Forecast, by Country, 2020-2034
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. By Drug Class,
9.6.2. By Distribution Channel
9.6.3. By Country

10. Europe Alzheimer’s Drugs Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Drug Class, 2020-2034
10.3.1. Cholinergic
10.3.2. Memantine
10.3.3. Combined Drugs
10.3.4. Others
10.4. Market Value Forecast, by Distribution Channel, 2020-2034
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Sales
10.5. Market Value Forecast, by Country/Sub-region, 2020-2034
10.5.1. Germany
10.5.2. U.K.
10.5.3. France
10.5.4. Italy
10.5.5. Spain
10.5.6. Rest of Europe
10.6. Market Attractiveness Analysis
10.6.1. By Drug Class
10.6.2. By Distribution Channel
10.6.3. By Country/Sub-region

11. Asia Pacific Alzheimer’s Drugs Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Drug Class, 2020-2034
11.3.1. Cholinergic
11.3.2. Memantine
11.3.3. Combined Drugs
11.3.4. Others
11.4. Market Value Forecast, by Distribution Channel, 2020-2034
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Sales
11.5. Market Value Forecast, by Country/Sub-region, 2020-2034
11.5.1. China
11.5.2. Japan
11.5.3. India
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia Pacific
11.6. Market Attractiveness Analysis
11.6.1. By Drug Class,
11.6.2. By Distribution Channel
11.6.3. By Country/Sub-region

12. Latin America Alzheimer’s Drugs Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Drug Class, 2020-2034
12.3.1. Cholinergic
12.3.2. Memantine
12.3.3. Combined Drugs
12.3.4. Others
12.4. Market Value Forecast, by Distribution Channel, 2020-2034
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Sales
12.5. Market Value Forecast, by Country/Sub-region, 2020-2034
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Market Attractiveness Analysis
12.6.1. By Drug Class,
12.6.2. By Distribution Channel
12.6.3. By Country/Sub-region

13. Middle East & Africa Alzheimer’s Drugs Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Drug Class, 2020-2034
13.3.1. Cholinergic
13.3.2. Memantine
13.3.3. Combined Drugs
13.3.4. Others
13.4. Market Value Forecast, by Distribution Channel, 2020-2034
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Sales
13.5. Market Value Forecast, by Country/Sub-region, 2020-2034
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of Middle East & Africa
13.6. Market Attractiveness Analysis
13.6.1. By Drug Class,
13.6.2. By Distribution Channel
13.6.3. By Country/Sub-region

14. Competition Landscape
14.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
14.2. Market Share Analysis, by Company (2023)
14.3. Company Profiles
14.3.1. Allergan plc
14.3.1.1. Company Overview
14.3.1.2. Technology, Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Financial Overview
14.3.1.5. Strategic Overview
14.3.2. Novartis AG
14.3.2.1. Company Overview
14.3.2.2. Technology, Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Financial Overview
14.3.2.5. Strategic Overview
14.3.3. Eisai Co. Ltd.
14.3.3.1. Company Overview
14.3.3.2. Technology, Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Financial Overview
14.3.3.5. Strategic Overview
14.3.4. Johnson & Johnson
14.3.4.1. Company Overview
14.3.4.2. Technology, Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Financial Overview
14.3.4.5. Strategic Overview
14.3.5. Daiichi Sankyo Company Limited
14.3.5.1. Company Overview
14.3.5.2. Technology, Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Financial Overview
14.3.5.5. Strategic Overview
14.3.6. Ono Pharmaceutical Co. Ltd.
14.3.6.1. Company Overview
14.3.6.2. Technology, Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Financial Overview
14.3.6.5. Strategic Overview
14.3.7. H Lundbeck A/S
14.3.7.1. Company Overview
14.3.7.2. Technology, Portfolio
14.3.7.3. SWOT Analysis
14.3.7.4. Financial Overview
14.3.7.5. Strategic Overview
14.3.8. Merz Holding GmbH & Co. KG
14.3.8.1. Company Overview
14.3.8.2. Technology, Portfolio
14.3.8.3. SWOT Analysis
14.3.8.4. Financial Overview
14.3.8.5. Strategic Overview

List of Tables

Table 01: Alzheimer’s Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2020-2034

Table 02: Alzheimer’s Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034

Table 03: Alzheimer’s Drugs Market Size (US$ Mn) Forecast, by Region, 2020-2034

Table 04: North America Alzheimer’s Drugs Market Size (US$ Mn) Forecast, by Country, 2020-2034

Table 05: North America Alzheimer’s Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2020-2034

Table 06: North America Alzheimer’s Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034

Table 07: Europe Alzheimer’s Drugs Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 08: Europe Alzheimer’s Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2020-2034

Table 09: Europe Alzheimer’s Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034

Table 10: Asia Pacific Alzheimer’s Drugs Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 11: Asia Pacific Alzheimer’s Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2020-2034

Table 12: Asia Pacific Alzheimer’s Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034

Table 13: Latin America Alzheimer’s Drugs Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 14: Latin America Alzheimer’s Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2020-2034

Table 15: Latin America Alzheimer’s Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034

Table 16: Middle East & Africa Alzheimer’s Drugs Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 17: Middle East & Africa Alzheimer’s Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2020-2034

Table 18: Middle East & Africa Alzheimer’s Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034

List of Figures

Figure 01: Alzheimer’s Drugs Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2034

Figure 02: Alzheimer’s Drugs Market Revenue (US$ Mn), by Drug Class, 2023

Figure 03: Alzheimer’s Drugs Market Value Share, by Drug Class, 2023

Figure 04: Alzheimer’s Drugs Market Revenue (US$ Mn), by Distribution Channel, 2023

Figure 05: Alzheimer’s Drugs Market Value Share, by Distribution Channel, 2023

Figure 06: Alzheimer’s Drugs Market Value Share, by Region, 2023

Figure 07: Alzheimer’s Drugs Market Value (US$ Mn) Forecast, 2020-2034

Figure 08: Alzheimer’s Drugs Market Value Share Analysis, by Drug Class, 2023 and 2034

Figure 09: Alzheimer’s Drugs Market Attractiveness Analysis, by Region, 2024-2034

Figure 10: Alzheimer’s Drugs Market Value Share Analysis, by Distribution Channel, 2023 and 2034

Figure 11: Alzheimer’s Drugs Market Attractiveness Analysis, by Distribution Channel, 2024-2034

Figure 12: Alzheimer’s Drugs Market Value Share Analysis, by Region, 2023 and 2034

Figure 13: Alzheimer’s Drugs Market Attractiveness Analysis, by Region, 2024-2034

Figure 14: North America Alzheimer’s Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 15: North America Alzheimer’s Drugs Market Attractiveness Analysis, by Country, 2024-2034

Figure 16: North America Alzheimer’s Drugs Market Value Share Analysis, by Country, 2023 and 2034

Figure 17: North America Alzheimer’s Drugs Market Value Share Analysis, by Drug Class, 2023 and 2034

Figure 18: North America Alzheimer’s Drugs Market Value Share Analysis, by Distribution Channel, 2023 and 2034

Figure 19: North America Alzheimer’s Drugs Market Attractiveness Analysis, by Region, 2024-2034

Figure 20: North America Alzheimer’s Drugs Market Attractiveness Analysis, by Distribution Channel, 2024-2034

Figure 21: Europe Alzheimer’s Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 22: Europe Alzheimer’s Drugs Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 23: Europe Alzheimer’s Drugs Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 24: Europe Alzheimer’s Drugs Market Value Share Analysis, by Drug Class, 2023 and 2034

Figure 25: Europe Alzheimer’s Drugs Market Value Share Analysis, by Distribution Channel, 2023 and 2034

Figure 26: Europe Alzheimer’s Drugs Market Attractiveness Analysis, by Region, 2024-2034

Figure 27: Europe Alzheimer’s Drugs Market Attractiveness Analysis, by Distribution Channel, 2024-2034

Figure 28: Asia Pacific Alzheimer’s Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 29: Asia Pacific Alzheimer’s Drugs Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 30: Asia Pacific Alzheimer’s Drugs Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 31: Asia Pacific Alzheimer’s Drugs Market Value Share Analysis, by Drug Class, 2023 and 2034

Figure 32: Asia Pacific Alzheimer’s Drugs Market Value Share Analysis, by Distribution Channel, 2023 and 2034

Figure 33: Asia Pacific Alzheimer’s Drugs Market Attractiveness Analysis, by Region, 2024-2034

Figure 34: Asia Pacific Alzheimer’s Drugs Market Attractiveness Analysis, by Distribution Channel, 2024-2034

Figure 35: Latin America Alzheimer’s Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 36: Latin America Alzheimer’s Drugs Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 37: Latin America Alzheimer’s Drugs Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 38: Latin America Alzheimer’s Drugs Market Value Share Analysis, by Drug Class, 2023 and 2034

Figure 39: Latin America Alzheimer’s Drugs Market Value Share Analysis, by Distribution Channel, 2023 and 2034

Figure 40: Latin America Alzheimer’s Drugs Market Attractiveness Analysis, by Region, 2024-2034

Figure 41: Latin America Alzheimer’s Drugs Market Attractiveness Analysis, by Distribution Channel, 2024-2034

Figure 42: Middle East & Africa Alzheimer’s Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 43: Middle East & Africa Alzheimer’s Drugs Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 44: Middle East & Africa Alzheimer’s Drugs Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 45: Middle East & Africa Alzheimer’s Drugs Market Value Share Analysis, by Drug Class, 2023 and 2034

Figure 46: Middle East & Africa Alzheimer’s Drugs Market Value Share Analysis, by Distribution Channel, 2023 and 2034

Figure 47: Middle East & Africa Alzheimer’s Drugs Market Attractiveness Analysis, by Region, 2024-2034

Figure 48: Middle East & Africa Alzheimer’s Drugs Market Attractiveness Analysis, by Distribution Channel, 2024-2034

△ 一番上に戻る